Peptide record

TPDB04966

Antibacterial Anticancer Antifungal Antiparasitic Antiviral Quorum sensing Toxicity standard
21 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB04966
Antibacterial Anticancer Antifungal Antiparasitic Antiviral Quorum sensing Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 Peptipedia AntiCP 2.0 iACP-DRLF Antifungipept dbAMP dbAMP 3.0 AI4AVP DRAMP DRAVP 2.0 EnsembleQS QSPred-FL ToxinPred 3.0
standard
No
A 21-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, Peptipedia, AntiCP 2.0, and other sources, with an available 3D structural model.
Sequence
CLGVGSCNDFAGCGYAIVCFW
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C97H137N23O27S4
REQHKMPT
CG
2185.53
3.10
0
1
10
-1
-0.94
1.157
74.29
Mammalian: 1.2 hour Yeast: >20 hour E.coli: >10 hour
7240
3.31
7
Residue Composition
number
2
A
0
R
1
N
1
D
4
C
0
E
0
Q
4
G
0
H
1
I
1
L
0
K
0
M
2
F
0
P
1
S
0
T
1
W
1
Y
2
V
Amino Acid Distribution
A: 2 R: 0 N: 1 D: 1 C: 4 E: 0 Q: 0 G: 4 H: 0 I: 1 L: 1 K: 0 M: 0 F: 2 P: 0 S: 1 T: 0 W: 1 Y: 1 V: 2
Chemical Descriptors
21 reviewed residue count
C97H137N23O27S4 sequence-only estimate (linear, free termini)
2185.53 sequence-only estimate (linear, free termini)
3.10 sequence-only estimate (linear, free termini)
-1 sequence-only estimate (linear, free termini)
-0.94 sequence-only estimate (linear, free termini)
1.157 sequence-only estimate (linear, free termini)
Evidence Records 1 records
Evidence 1 Activity

Activity

50% Cytotoxicity
Toxicity
>500 µg/mL
Cytotoxic
50% Cytotoxicity | >500 | µg/mL | target cell: CEM-SS cells

Target

CEM-SS cells

Source & Reference

NA
DBAASP
Siamycins I and II, new anti-HIV peptides: I. Fermentation, isolation, biological activity and initial characterization. | J Antibiot (Tokyo) | 1995